Pfizer and Modern have raised the price of their vaccines in recent EU supply contracts. According to reports from the Financial Times, Pfizer has raised the price of its vaccine by more than 25% and Moderna by more than 10%. The terms of the agreements, totaling over 2.1 billion doses until 2023, have been renegotiated. And that’s after data from Phase 3 studies showed that the mRNA vaccines from the two drug companies are more effective than the cheaper vaccines developed by Oxford-AstraZeneca and Johnson & Johnson.
The new price for the preparation Pfizer is € 19.50 per dose compared to € 15.50 for the previous supply. The price of Moderna is 25.50 euros per dose against the 19 of the previous supply, but in this case the negotiation went in favor of the buyer because at a certain point the price had risen to € 28.50, explains the English newspaper. “The best conditions – albeit with a substantial increase compared to the past – have been granted in the face of a more substantial order. The European Commission on Tuesday 27 July announced that by the summer it will be able to reach the immunization target of 70. % of the adult population. Reuters reports that neither Pfizer nor Moderna wanted to comment on the news of the price increase, “he reveals. Republic.
.
Meanwhile, the Italians who have closed the vaccination cycle have passed share 32.4 million, 60% of the audience to be vaccinated made up of those over 12 years old, makes known the structure of Commissioner Figliuolo. “A first important result that allows us to look to the future with greater confidence”, comments the Minister of Health Speranza. The average is 500,000 administrations per day, further doses of Pfizer vaccine from the third week of August. Community immunity is aimed at by the end of September, with the complete vaccination course for 80%.
Videos on this topic
– .
